SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,548,000 | -85.0% | 14,000 | -89.9% | 0.01% | -80.0% |
| Q2 2022 | $10,344,000 | +3.5% | 138,000 | +7.8% | 0.02% | +47.1% |
| Q1 2022 | $9,999,000 | +808.2% | 128,000 | +947.2% | 0.02% | +750.0% |
| Q4 2021 | $1,101,000 | -94.3% | 12,223 | -94.2% | 0.00% | -94.1% |
| Q3 2021 | $19,339,000 | +3814.8% | 209,118 | +3188.5% | 0.03% | +3300.0% |
| Q2 2021 | $494,000 | -94.6% | 6,359 | -90.2% | 0.00% | -96.0% |
| Q3 2020 | $9,142,000 | +95.4% | 65,098 | +123.1% | 0.02% | +56.2% |
| Q2 2020 | $4,678,000 | -3.5% | 29,176 | -54.7% | 0.02% | +14.3% |
| Q3 2019 | $4,850,000 | +408.4% | 64,392 | +926.2% | 0.01% | +250.0% |
| Q2 2019 | $954,000 | 0.0% | 6,275 | -21.6% | 0.00% | 0.0% |
| Q1 2019 | $954,000 | -66.4% | 8,000 | -69.2% | 0.00% | -69.2% |
| Q4 2018 | $2,837,000 | +55.0% | 26,000 | +5.3% | 0.01% | +44.4% |
| Q1 2018 | $1,830,000 | -66.9% | 24,700 | -79.7% | 0.01% | -71.9% |
| Q3 2017 | $5,523,000 | – | 121,767 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |